Malignancy
Item
relapsed/refractory non-small cell lung cancer, colorectal adenocarcinoma, malignant melanoma, renal (clear) cell carcinoma, or hormone-refractory prostate adenocarcinoma
boolean
C0006826 (UMLS CUI [1])
Prior treatment
Item
prior treatment must have been completed at least 4 weeks prior to enrollment
boolean
C1514463 (UMLS CUI [1])
Primary or metastatic brain or meningeal tumors
Item
no untreated primary or metastatic brain or meningeal tumors
boolean
C0750974 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0025284 (UMLS CUI [3])
ECOG
Item
ecog ps 0 or 1
boolean
C1520224 (UMLS CUI [1])
Laboratory values
Item
meet all screening laboratory values
boolean
C0022885 (UMLS CUI [1])
Hypersensitivity to monoclonal antibodies
Item
history of severe hypersensitivity reactions to other monoclonal antibodies
boolean
C0020517 (UMLS CUI [1,1])
C3542957 (UMLS CUI [1,2])
Autoimmune disease
Item
active autoimmune disease or a documented history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Anti-pd-1 or anti-ctla-4 antibody
Item
prior therapy with an anti-pd-1 or anti-ctla-4 antibody
boolean
C4053601 (UMLS CUI [1])
C2986402 (UMLS CUI [2])
Active infection
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Immunosuppressive medications
Item
concurrent medical condition requiring the use of immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])